0001209191-19-054066.txt : 20191025
0001209191-19-054066.hdr.sgml : 20191025
20191025141025
ACCESSION NUMBER: 0001209191-19-054066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191025
FILED AS OF DATE: 20191025
DATE AS OF CHANGE: 20191025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HSIAO JANE PH D
CENTRAL INDEX KEY: 0001188834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33528
FILM NUMBER: 191169245
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BLVD
CITY: MIAMI
STATE: FL
ZIP: 33137
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Opko Health, Inc.
CENTRAL INDEX KEY: 0000944809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 752402409
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
CITY: MIAMI
STATE: FL
ZIP: 33137
BUSINESS PHONE: 305-575-4138
MAIL ADDRESS:
STREET 1: 4400 BISCAYNE BLVD.
CITY: MIAMI
STATE: FL
ZIP: 33137
FORMER COMPANY:
FORMER CONFORMED NAME: eXegenics Inc
DATE OF NAME CHANGE: 20040505
FORMER COMPANY:
FORMER CONFORMED NAME: EXEGENICS INC
DATE OF NAME CHANGE: 20011114
FORMER COMPANY:
FORMER CONFORMED NAME: CYTOCLONAL PHARMACEUTICS INC /DE
DATE OF NAME CHANGE: 19950503
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-25
0
0000944809
Opko Health, Inc.
OPK
0001188834
HSIAO JANE PH D
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.
MIAMI
FL
33137
1
1
0
0
Vice Chairman & CTO
Common Stock
24475147
D
Common Stock
2019-10-25
4
P
0
400000
1.50
A
5127404
I
See Footnote
Common Stock
20091062
I
See Footnote
The securities are owned directly by Hsu Gamma Investment, L.P. Dr. Hsiao is the general partner of Hsu Gamma Investment, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
These securities are owned directly by The Frost Group, LLC. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Jane H. Hsiao, Ph.D.
2019-10-25